Malignant Neoplasm of Stomach Unknown Status Phase 2 Trials for Docetaxel (DB01248)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01618474Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer PatientsTreatment
NCT00075465Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the StomachTreatment
NCT00865982Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal CancerTreatment
NCT00980603Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric CancerTreatment
NCT01718626Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric CancerTreatment
NCT01747707Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction CancerTreatment